Article Details
Retrieved on: 2021-08-02 16:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Ipsen is shoring up its neuroscience pipeline via a deal that gives it the option to license drugs that Exicure is developing for Huntington's disease and ...
Article found on: medcitynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here